ATE392887T1 - Stabilisierte arzneizusammensetzungen zur parenteralen vearbreichung - Google Patents

Stabilisierte arzneizusammensetzungen zur parenteralen vearbreichung

Info

Publication number: ATE392887T1
Authority: AT; Austria
Prior art keywords: compounds; parenteral administration; lambda; warm; alpha
Prior art date: 2000-10-10

Application number

AT01308284T

Other languages

English (en)

Inventor

William David Steber

Original Assignee

Wyeth Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-10

Filing date

2001-09-28

Publication date

2008-05-15

2001-09-28 Application filed by Wyeth Corp filed Critical Wyeth Corp

2008-05-15 Application granted granted Critical

2008-05-15 Publication of ATE392887T1 publication Critical patent/ATE392887T1/de

Links

239000000203 mixture Substances 0.000 title abstract 4
238000007911 parenteral administration Methods 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 4
241001465754 Metazoa Species 0.000 abstract 2
YNFMRVVYUVPIAN-UHFFFAOYSA-N nemadectin alpha Natural products C1C(O)C(C)C(C(C)=CC(C)C)OC11OC(CC=C(C)CC(C)C=CC=C2C3(C(C(=O)O4)C=C(C)C(O)C3OC2)O)CC4C1 YNFMRVVYUVPIAN-UHFFFAOYSA-N 0.000 abstract 2
241000238421 Arthropoda Species 0.000 abstract 1
241000244206 Nematoda Species 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical class C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
244000000013 helminth Species 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000004005 microsphere Substances 0.000 abstract 1
FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Chemical class COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 abstract 1
YNFMRVVYUVPIAN-AQUURSMBSA-N nemadectin Chemical compound C1[C@H](O)[C@H](C)[C@@H](C(/C)=C/C(C)C)O[C@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YNFMRVVYUVPIAN-AQUURSMBSA-N 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Tropical Medicine & Parasitology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Biophysics (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT01308284T 2000-10-10 2001-09-28 Stabilisierte arzneizusammensetzungen zur parenteralen vearbreichung ATE392887T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US23892500P	2000-10-10	2000-10-10

Publications (1)

Publication Number	Publication Date
ATE392887T1 true ATE392887T1 (de)	2008-05-15

Family

ID=22899893

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01308284T ATE392887T1 (de)	2000-10-10	2001-09-28	Stabilisierte arzneizusammensetzungen zur parenteralen vearbreichung

Country Status (9)

Country	Link
EP (1)	EP1197207B1 (de)
JP (1)	JP4221170B2 (de)
AT (1)	ATE392887T1 (de)
CA (1)	CA2358361C (de)
CY (1)	CY1108145T1 (de)
DE (1)	DE60133706T2 (de)
DK (1)	DK1197207T3 (de)
ES (1)	ES2304371T3 (de)
PT (1)	PT1197207E (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2852843B1 (fr)	2003-03-24	2008-05-23	Karim Ioualalen	Systeme galenique permettant le masquage du gout
FR2913884A1 (fr) *	2007-03-21	2008-09-26	Oralance Pharma Sa	Systeme galenique hydrophobe non ionisable
ITUB20153652A1 (it) *	2015-09-16	2017-03-16	Fatro Spa	Microsfere contenenti lattoni macrociclici antielminitici
KR102101969B1 (ko)	2017-09-06	2020-04-22	(주)인벤티지랩	목시덱틴을 포함하는 마이크로 입자 및 이의 제조 방법
WO2020225143A1 (en)	2019-05-03	2020-11-12	Intervet International B.V.	Injectable pharmaceutical compositions and uses thereof
WO2021233967A1 (en)	2020-05-20	2021-11-25	Intervet International B.V.	Injectable pharmaceutical compositions and uses thereof
WO2024003291A1 (en)	2022-06-30	2024-01-04	Virbac	Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction
WO2026041795A1 (en)	2024-08-23	2026-02-26	Intervet International B.V.	Injectable veterinary composition for cattle

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5213810A (en) *	1990-03-30	1993-05-25	American Cyanamid Company	Stable compositions for parenteral administration and method of making same
US5733566A (en) *	1990-05-15	1998-03-31	Alkermes Controlled Therapeutics Inc. Ii	Controlled release of antiparasitic agents in animals
ATE134873T1 (de) *	1991-07-23	1996-03-15	American Cyanamid Co	Stabile zusammensetzungen für parenterale verabrechung und ihre verwendung
GB2310801A (en) *	1996-03-04	1997-09-10	Merck & Co Inc	Process for removing an organic solvent from lactide-glycoside copolymer microspheres

2001
- 2001-09-28 AT AT01308284T patent/ATE392887T1/de active
- 2001-09-28 PT PT01308284T patent/PT1197207E/pt unknown
- 2001-09-28 DE DE60133706T patent/DE60133706T2/de not_active Expired - Lifetime
- 2001-09-28 EP EP01308284A patent/EP1197207B1/de not_active Expired - Lifetime
- 2001-09-28 DK DK01308284T patent/DK1197207T3/da active
- 2001-09-28 ES ES01308284T patent/ES2304371T3/es not_active Expired - Lifetime
- 2001-10-03 JP JP2001307295A patent/JP4221170B2/ja not_active Expired - Lifetime
- 2001-10-05 CA CA002358361A patent/CA2358361C/en not_active Expired - Lifetime
2008
- 2008-06-17 CY CY20081100639T patent/CY1108145T1/el unknown

Also Published As

Publication number	Publication date
AU784023B2 (en)	2006-01-19
CA2358361A1 (en)	2002-04-10
EP1197207B1 (de)	2008-04-23
JP2002161033A (ja)	2002-06-04
CY1108145T1 (el)	2013-03-13
PT1197207E (pt)	2008-07-01
DE60133706T2 (de)	2009-07-02
AU7827301A (en)	2002-04-11
JP4221170B2 (ja)	2009-02-12
CA2358361C (en)	2009-08-11
ES2304371T3 (es)	2008-10-16
DE60133706D1 (de)	2008-06-05
EP1197207A3 (de)	2003-02-05
EP1197207A2 (de)	2002-04-17
DK1197207T3 (da)	2008-08-04

Legal Events

Date

Code

Title

Description

2008-10-15

UEP

Publication of translation of european patent specification

Ref document number: 1197207

Country of ref document: EP

2011-12-15

EEIH

Change in the person of patent owner

Publication	Publication Date	Title
DK0525307T3 (da)	1996-04-01	Stabile præparater til parenteral indgivelse og deres anvendelse
CY1108145T1 (el)	2013-03-13	Σταθερες συνθεσεις για παρεντερικη χορηγηση
DK1087960T3 (da)	2011-06-14	Makrocykliske analoger og fremgangsmåder til deres anvendelse og fremstilling
DK1207756T3 (da)	2006-08-14	Anvendelse af spinosad eller en formulering, der omfatter spinosad
CY1110261T1 (el)	2012-05-23	Παραγωγα της κουμαρινης που χρησιμοποιουνται σαν αντιπηκτικα
FI973409A0 (fi)	1997-08-20	Loisten häätöön tarkoitettu valmiste
CY1107819T1 (el)	2013-06-19	Φαρμακευτικη διαμορφωση της ολανζαπινης
EE200100433A (et)	2002-12-16	Klaritromütsiini, rasv- ja hüdrofiilse komponendisegu sisaldav farmatseutiline preparaat, meetod selle valmistamiseks ning kasutamine
AP2004003106A0 (en)	2004-09-30	Synergistic insecticidal mixtures.
EA201101119A1 (ru)	2011-12-30	Дозируемая форма, содержащая пантопразол в качестве активного ингредиента
TW200420554A (en)	2004-10-16	A intra-airway administrating preparation
DE69331007D1 (de)	2001-11-29	Difluoroavermectin-derivate
WO2004098577A3 (en)	2004-12-09	Dosage form containing (s)-pantoprazole as active ingredient
BR0109891A (pt)	2002-12-31	Composição farmaceutica contendo derivado de camptotecina e substância de ajuste de ph
EA200601015A1 (ru)	2006-10-27	Пероральные композиции дезоксипеганина и их применение
ES2080175T3 (es)	1996-02-01	Estabilizador para una preparacion que contiene 4-etil-2-hidroxiimino-5-nitro-3-hexenamida y metodo de estabilizacion correspondiente.
BG60271B1 (bg)	1994-03-31	13-алкил-23-имино и 13-хало-23-имино производни на ll-f28249 и приложението им като ендо- и ектопаразитицидни, инсектицидни, акарицидни и нематоцидни средства
WO2004072037A8 (en)	2005-09-29	2,3'-bipyridines derivatives as selective cox-2 inhibitors
WO2005027903A8 (en)	2006-04-27	Polyether brevetoxin derivatives as a treatment for neurotoxic shellfish poisoning and ciguatera fish poisoning
DK1100463T3 (da)	2003-01-20	Injicerbare formuleringer indeholdende ramoplanin